These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38331716)

  • 41. Triclosan can select for an AdeIJK-overexpressing mutant of Acinetobacter baumannii ATCC 17978 that displays reduced susceptibility to multiple antibiotics.
    Fernando DM; Xu W; Loewen PC; Zhanel GG; Kumar A
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6424-31. PubMed ID: 25136007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
    Fuchs F; Becerra-Aparicio F; Xanthopoulou K; Seifert H; Higgins PG
    J Antimicrob Chemother; 2022 Jun; 77(7):1912-1915. PubMed ID: 35411393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insight into carbapenem resistance and virulence of Acinetobacter baumannii from a children's medical centre in eastern China.
    Zhu Y; Zhang X; Wang Y; Tao Y; Shao X; Li Y; Li W
    Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):47. PubMed ID: 36335338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam.
    Tuan Anh N; Nga TVT; Tuan HM; Tuan NS; Y DM; Vinh Chau NV; Baker S; Duong HHT
    J Med Microbiol; 2017 Jan; 66(1):46-53. PubMed ID: 28198682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenotypic and molecular characterisations of carbapenem-resistant
    Simo Tchuinte PL; Rabenandrasana MAN; Kowalewicz C; Andrianoelina VH; Rakotondrasoa A; Andrianirina ZZ; Enouf V; Ratsima EH; Randrianirina F; Collard JM
    Antimicrob Resist Infect Control; 2019; 8():31. PubMed ID: 30792853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran.
    Salehi B; Ghalavand Z; Mohammadzadeh M; Maleki DT; Kodori M; Kadkhoda H
    J Appl Microbiol; 2019 Nov; 127(5):1421-1429. PubMed ID: 31400237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A plethora of carbapenem resistance in
    Vahhabi A; Hasani A; Rezaee MA; Baradaran B; Hasani A; Samadi Kafil H; Abbaszadeh F; Dehghani L
    J Chemother; 2021 May; 33(3):137-155. PubMed ID: 33243098
    [No Abstract]   [Full Text] [Related]  

  • 48. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
    Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
    Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AdeR-AdeS mutations & overexpression of the AdeABC efflux system in ciprofloxacin-resistant
    Lari AR; Ardebili A; Hashemi A
    Indian J Med Res; 2018 Apr; 147(4):413-421. PubMed ID: 29998878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Lee S; Razqan GS; Kwon DH
    Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Whole Genome Analysis of Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates in Thailand.
    Chopjitt P; Kerdsin A; Takeuchi D; Hatrongjit R; Boueroy P; Akeda Y; Tomono K; Hamada S
    Infect Disord Drug Targets; 2021; 21(5):e270421188042. PubMed ID: 33200701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
    Cakirlar FK; Ciftci IH; Gonullu N
    Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
    Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
    Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.
    Jo J; Ko KS
    Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.
    Rumbo C; Gato E; López M; Ruiz de Alegría C; Fernández-Cuenca F; Martínez-Martínez L; Vila J; Pachón J; Cisneros JM; Rodríguez-Baño J; Pascual A; Bou G; Tomás M; ; ;
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5247-57. PubMed ID: 23939894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates.
    Li H; Wang X; Zhang Y; Zhao C; Chen H; Jiang S; Zhang F; Wang H
    Future Microbiol; 2015; 10(3):337-46. PubMed ID: 25812457
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study.
    Khanjani S; Sedigh Ebrahim-Saraie H; Shenagari M; Ashraf A; Mojtahedi A; Atrkar Roushan Z
    Acta Microbiol Immunol Hung; 2020 Mar; 67(3):182-186. PubMed ID: 32160785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.